The combined dose–response curves for IXA vs. BTZ sensitivity in ALL and AML samples are shown in Figure 4B. Next, we examined whether the LC50 values for IXA and BTZ were correlated (Figure 4C). This evidence concerns the gene CASC3 and acute myeloid leukemia.